These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22834407)

  • 1. Improvement of the bitter taste of drugs by complexation with cyclodextrins: applications, evaluations and mechanisms.
    Arima H; Higashi T; Motoyama K
    Ther Deliv; 2012 May; 3(5):633-44. PubMed ID: 22834407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of some physicochemical properties of arundic acid, (R)-(-)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins.
    Miyamoto Y; Nakahara M; Motoyama K; Ishiguro T; Oda Y; Yamanoi T; Okamoto I; Yagi A; Nishimura H; Hirayama F; Uekama K; Arima H
    Int J Pharm; 2011 Jul; 413(1-2):63-72. PubMed ID: 21540089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Original research paper. Characterization and taste masking evaluation of microparticles with cetirizine dihydrochloride and methacrylate-based copolymer obtained by spray drying.
    Amelian A; Szekalska M; Ciosek P; Basa A; Winnicka K
    Acta Pharm; 2017 Mar; 67(1):113-124. PubMed ID: 28231047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taste-masking assessment of solid oral dosage forms--a critical review.
    Pein M; Preis M; Eckert C; Kiene FE
    Int J Pharm; 2014 Apr; 465(1-2):239-54. PubMed ID: 24509066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent patents and patented technology platforms for pharmaceutical taste masking.
    Kaushik D; Dureja H
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):37-45. PubMed ID: 24499438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical approaches of taste masking technologies in oral solid forms.
    Douroumis D
    Expert Opin Drug Deliv; 2007 Jul; 4(4):417-26. PubMed ID: 17683254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
    Drašković M; Medarević D; Aleksić I; Parojčić J
    Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of taste masked famotidine formulation using drug/beta-cyclodextrin/polymer ternary complexation approach.
    Patel AR; Vavia PR
    AAPS PharmSciTech; 2008; 9(2):544-50. PubMed ID: 18431648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of Applications of Cyclodextrins as Taste-Masking Excipients for Pharmaceutical Purposes.
    Adamkiewicz L; Szeleszczuk Ł
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.
    Simšič T; Planinšek O; Baumgartner A
    Acta Pharm; 2024 Jun; 74(2):177-199. PubMed ID: 38815202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on the taste masking of bitter APIs: hot-melt extrusion (HME) evaluation.
    Maniruzzaman M; Boateng JS; Chowdhry BZ; Snowden MJ; Douroumis D
    Drug Dev Ind Pharm; 2014 Feb; 40(2):145-56. PubMed ID: 23763436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Taste-masking possibilities in solid dosage forms].
    Szakonyi G; Zelkó R
    Acta Pharm Hung; 2012; 82(2):81-90. PubMed ID: 22870781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bitter-blockers as a taste masking strategy: A systematic review towards their utility in pharmaceuticals.
    Andrews D; Salunke S; Cram A; Bennett J; Ives RS; Basit AW; Tuleu C
    Eur J Pharm Biopharm; 2021 Jan; 158():35-51. PubMed ID: 33130339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.
    Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Ishiguro T; Hirayama F; Uekama K; Otagiri M
    J Pharm Sci; 2010 Oct; 99(10):4285-94. PubMed ID: 20737636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of polymers for taste-masking pediatric drug products.
    Felton LA
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1049-1055. PubMed ID: 29357707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masking mechanisms of bitter taste of drugs studied with ion selective electrodes.
    Funasaki N; Uratsuji I; Okuno T; Hirota S; Neya S
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1155-61. PubMed ID: 16880661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of a modified special-cubic design and an electronic tongue for bitterness masking formulation optimization.
    Li L; Naini V; Ahmed SU
    J Pharm Sci; 2007 Oct; 96(10):2723-34. PubMed ID: 17506509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.
    Rahman Z; Zidan AS; Berendt RT; Khan MA
    Int J Pharm; 2012 Jan; 422(1-2):91-100. PubMed ID: 22037447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific interactions between diphenhydramine and alpha-helical poly(glutamic acid)--a new ion-pairing complex for taste masking and pH-controlled diphenhydramine release.
    Agresti C; Tu Z; Ng C; Yang Y; Liang JF
    Eur J Pharm Biopharm; 2008 Sep; 70(1):226-33. PubMed ID: 18514496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA; Carrier RL; Ahmed I
    J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.